The herpes simplex virus (HSV) triplex is a complex of three protein subunits, VP19C and a dimer of VP23 that is essential for capsid assembly. We have derived HSV-1 recombinant viruses that contain monomeric red fluorescent protein (mRFP1), a Flu hemagglutinin (HA) epitope, and a six-histidine tag fused to the amino terminus of VP19C. These viruses were capable of growth on Vero cells, indicating that the amino terminus of VP19C could tolerate these fusions. By use of immunoelectron microscopy methods, capsids that express VP19C-mRFP but not VP19C-HA were labeled with gold particles when incubated with the corresponding antibody. Our conclusion from the data is that a large tag at the N terminus of VP19C was sufficiently exposed on the capsid surface for polyclonal antibody reactivity, while the small HA epitope was inaccessible to the antibody. These data indicate that an epitope tag at the amino terminus of VP19C is not exposed at the capsid surface for reactivity to its antibody.
Capsid assembly for herpesviruses is a nuclear event resulting in the production of four closed structures, the spherical procapsid and the angular A, B, and C capsids (5, 7) . B capsids contain internal scaffold proteins (p22a and p21), the viral protease (VP24), and the capsid shell proteins (VP5, VP19C, VP23, and VP26). For C capsids, genomic DNA replaces the scaffold proteins, and A capsids are empty capsids (reviewed in references 10 and 13). A heterotrimeric complex of one molecule of VP19C and two molecules of VP23 is important for the assembly of the capsid shell structure; if either is absent, capsid shells do not form (4, 9, 15, 16) . This complex, designated the triplex, is a unique feature of herpesvirus capsid architecture.
Previously, we discovered that a VP19C construct that expressed an N-terminal histidine handle was capable of participating in assembly to give icosahedral capsids in insect cells using recombinant baculoviruses (8) . Spencer et al. (11) first demonstrated that the N-terminal 90 amino acids of VP19C were not required for capsid assembly in the baculovirus system; more recently, similar results were seen in an extensive mutational analysis by Adamson et al. (1) . The goal of the present study was to take advantage of these data and to determine whether herpes simplex virus type 1 (HSV-1) recombinant viruses that express an N-terminally tagged VP19C could be made. Subsequently, the accessibility of the N-terminal tag on the capsid surface could be determined by immunoelectron microscopy (immuno-EM) methods. Using this approach of ligand-specific detection, one can elucidate the topography of a protein or a domain in a three-dimensional structure, such as the HSV-1 capsid.
For this study, a SpeI restriction enzyme site was inserted just after the start of VP19C translation using PCR-based methods. This restriction site (ACTAGT) encodes threonine/ serine codons after the start of VP19C translation. This plasmid was designated pKUL38Spe1; the parental plasmid pKUL38 has been described before (9) . Oligonucleotides which, once annealed, create the Flu hemagglutinin (HA) epitope (YPYDVPDYA) and a six-histidine domain (SSHHH HHHGS) were made and cloned into the SpeI site of pKUL38Spe1, giving plasmids pKUL38-HA and pKUL38-HIS, respectively. The monomeric red fluorescent protein (mRFP1) open reading frame (2) was amplified using PfuTurbo polymerase (Stratagene). The PCR product was digested with SpeI and cloned into pKUL38Spe1 to create pKUL38-mRFP. All constructs were sequenced for authentic amplification and orientation. These constructs were recombined into the HSV-1 genome using homologous recombination. The recipient genome used for this was K⌬19C, which contains a null mutation in the gene encoding this protein (9) . Cotransfection of plasmid and viral DNA was performed with C32 cells, a VP19C-complementing cell line (9) . The transfection progeny were plated on both C32 and Vero cell monolayers to detect recombinant viruses. Plaques were detected on Vero cells for viruses that expressed VP19C-HA, VP19C-HIS, and VP19C-mRFP. The above three viruses, designated K19C-mRFP, K19C-HA, and K19C-HIS, were plaque purified, and insertion of the tag sequence in the genome was confirmed by PCR assays. The construct that encodes the SpeI restriction site after the start of VP19C translation was also recombined into the K⌬19C virus, and a virus designated K19C-Spe1 was isolated on Vero cells and plaque purified further.
The growth properties of the recombinant viruses were examined by infecting Vero and C32 cells and determining virus yields at different times postinfection (Fig. 1 ). K19C-Spe1, K19C-HA, and K19C-HIS gave rise to virus yields that were comparable to those of the wild-type virus, KOS, at 24 h postinfection ( Fig. 1) . The growth of K19C-mRFP was reduced 14-fold relative to that of the wild-type virus (Fig. 1) . The growth of K19C-mRFP was recovered partially (sevenfold) by replication in the complementing cell line C32 (Fig. 1) . The VP19C trans complementation in C32 cells was never at the level seen for wild-type virus (data not shown). The growth of K19C-Spe1 was comparable to that of wild-type virus, indicating that the SpeI site did not alter virus replication (Fig. 1) .
To confirm the expression of the tagged VP19C polypeptides, infected Vero cell lysates were analyzed at different times postinfection using antibodies to the different tags in Western blot assays (Fig. 2 ). In the case of antibodies to HA, six-histidine, and DsRed, a polypeptide with the correct mobility was detected in extracts derived from cells infected with the respective virus (Fig.  2) . The DsRed antibody also recognizes mRFP protein. There was little reactivity of the antibodies to either the wild-type protein or mock-infected cell proteins. There was a corresponding mobility shift in the VP19C-mRFP polypeptide due to the fusion of the mRFP (25 kDa) to VP19C (50 kDa). VP19C-HA and VP19C-HIS polypeptides also exhibited slightly slower mobilities relative to that of the wild-type protein (Fig. 2) . Since VP19C is expressed from a late gene, there is very little protein accumulation at 8 h postinfection. The highly reactive HA antibody was able to detect low amounts of this protein at early times (Fig. 2, ␣HA panel) . ) were infected with the viruses indicated at the top of each panel at a multiplicity of infection of 10 PFU/cell, and the cells were harvested 8 and 24 h postinfection (MI, mock infected). Total cell lysates prepared were transferred to nylon membranes and then probed using antibodies. Blots probed with ␣HA, ␣HIS, and ␣DsRed were processed using the enhanced chemiluminescence method, and the blot probed with ␣UL38C was processed using 125 I-Protein A (8). The UL38C rabbit antiserum (␣UL38C) was raised against a C terminus peptide (VILEGVVWRPG EWRA) spanning amino acids 449 to 463 of VP19C. The DsRed polyclonal rabbit antiserum, anti-HA mouse monoclonal antibody, and anti-HIS mouse monoclonal antibody were obtained from BD Biosciences, Sigma, and Molecular Probes, respectively. (9, 17) . The polypeptide composition of the capsids was examined by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (Fig. 3) . The mature C capsid fractions for all the viruses were examined. The capsids isolated all contained the capsid shell proteins; the only difference between the different capsids was the lower mobility of the tagged VP19C polypeptides, which was more evident for the VP19C-mRFP polypeptide (Fig. 3, filled circle) . The levels of C capsids derived from K19C-mRFP-infected cell lysates were much lower than the levels of C capsids derived from infected cell lysates of the other viruses (Fig. 3) . In order to determine the surface topology of the different tags fused to VP19C, we carried out immuno-EM for purified capsids using antibodies to the various tags (Fig. 4) . B capsids were purified after sedimentation of infected cell lysates through sucrose gradients. Capsids were adsorbed by placing a drop on freshly ionized carbon-and Formvar-coated nickel grids for 5 min, washed eight times by floating grids on a series of drops of deionized H 2 O, and blocked for 1 h on a drop of 10% fetal calf serum in phosphate-buffered saline. Grids were then floated on a 10-l drop of either rabbit anti-DsRed (mRFP), 10 g/ml (Chemicon AB3216), mouse anti-HA (33 g/ml; Covance 12CA5), or mouse anti-VP5 (diluted 1:20; LP12) and incubated at 4°C overnight. Grids were washed eight times in a wash buffer (1% fetal calf serum in phosphatebuffered saline) and floated on 10-l donkey anti-rabbit 12-nm Au conjugate (diluted 1:30) or donkey anti-mouse 12-nm Au conjugate (diluted 1:40) (Jackson Research Laboratories) for 2 h at room temperature, washed eight times with wash buffer and five times with deionized H 2 O, briefly floated on a drop of 2% uranyl acetate, partially dried by touching the side of the grid to filter paper, allowed to air dry, and observed with a Immuno-EM analysis of VP19C-tagged capsids. Immuno-EM was used to determine the accessibility at the surfaces of the capsid of HA and mRFP tags fused to the N terminus of VP19C. Purified B capsids isolated from sucrose gradients (17) were adsorbed to grids, reacted with antisera to DsRed (A and B), HA (C and D) or VP5 (LP12 [E]) and detected with 12-nm gold-labeled secondary antibody following negative staining with uranyl acetate. Gold particles were readily detected bound to KOS capsids when VP5 antibody (LP12) was used (E). Gold was not detected bound to KOS capsids when DsRed (A) and HA (C) antibodies were used. Occasionally, nonspecific gold particles were shown to bind to KOS capsids (arrowhead in panel A). Gold was detected bound to the K19C-mRFP capsids (arrowheads in panel B) but not to the K19C-HA capsids (D). Scale bar ϭ 200 nm. 4E) were evident when VP5 antibodies (LP12) were used. None or very few gold particles were bound to KOS capsids when HA (Fig. 4C) or DsRed (Fig. 4A) antibodies were used. K19C-HA capsids exhibited little or no labeling when the capsids were reacted with HA antisera (Fig. 4D, arrowhead) . This was not due to the loss of the epitope, because with similar sucrose gradient fractions, a 50-kDa polypeptide reacted with HA antisera in Western blots (data not shown). Many gold particles were observed bound to K19C-mRFP B capsids when DsRed antibody was used (Fig. 4B) . A quantitative analysis was performed for these capsids as well as for KOS B capsids reacted with DsRed antibody. Intact capsids were enumerated, and the number of gold particles bound to the capsids was determined. The data revealed that KOS capsids exhibited little or no labeling (KOS, 0.27 gold particles/capsid) but that K19C-mRFP capsids exhibited significant labeling compared to KOS capsids (K19C-mRFP, 4.41 gold particles/capsid; t ϭ 9.12; P value, 2.85 ϫ 10 Ϫ17 ; n ϭ 41 [one-tailed t test]). The mRFP tag was the only one that reacted with its cognate antibody, as judged by gold binding. We also generated a virus in which the HA tag was followed by a small peptide spacer sequence [Pro (Ser, Ala) 4 Pro] prior to the VP19C sequence. It was thought that this spacer sequence may expose the HA sequence at the capsid shell surface. B capsids isolated from this virus similarly did not react with antibodies to HA (data not shown).
Because many of our studies have generally focused on studying bimolecular protein-protein interactions in isolated systems, our goal was to probe a multiprotein complex to ascertain the topology of protein domains. Hence, our aim was to determine the location of the N terminus of VP19C on the capsid shell. Use of this method of residue-specific ligand attachment to locate a protein domain in conjunction with highresolution cryo-EM could potentially yield a three-dimensional map of the structural motif in the capsid shell. This method has been used successfully to locate the protein domains in the capsids of viruses (3, 6, 12, 14, 18) . However, by using immuno-EM methods, it was not possible to detect the tag in the assembled capsid, indicating that the HA epitope was not exposed on the surface of the capsid. It is also possible, in the absence of a positive result from the HA tag, that the epitope is masked in the assembled shell even though the N terminus of VP19C is on the surface. However, the larger mRFP fusion protein somehow allowed for exposure of some or all epitopes of mRFP (polyclonal sera) on the capsid surface and gave reactivity to the antibody. Thus, one conclusion from the data is that the amino terminus of VP19C may not be exposed on the surface of the capsid shell, as judged by immuno-EM methods.
